Physician profile
Leland Deane
NPI 1770552911
$3,709.45
in general payments reported to CMS, 2019-2025
8 companies · $29.54 in 2025
The $29.54 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $16.43 · 2021: $202 · 2022: $721 · 2023: $1,012 · 2024: $667 · 2025: $29.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,381 · Food and Beverage: $273 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,380.95 |
| Food and Beverage | $273.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,616.90 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $1,581.25 | 2019-2022 | |
| Mentor Worldwide LLC | $304.52 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $129.37 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $25.50 | 2019-2023 | Exparel |
| Galderma Laboratories, L.P. | $19.88 | 2021 | |
| Coopersurgical, INC. | $16.43 | 2020 | |
| Kci USA, INC. | $15.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leland Deane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.